Management of incidental STIC lesions with and without BRCA mutations: a survey of current clinical practice in Austria, Germany, and Switzerland - Summary - MDSpire

Management of incidental STIC lesions with and without BRCA mutations: a survey of current clinical practice in Austria, Germany, and Switzerland

  • By

  • Natalia Anna Kaufmann

  • Peter Oppelt

  • Christoph Grimm

  • Julia Lastinger

  • Teresa Eichinger

  • Philip Trautner

  • Anja Hartl

  • Stefan Raidl

  • Dariga Ramazanova

  • Caroline Ines Preuss

  • April 20, 2026

  • 0 min

Share

Objective:

To assess clinical practice and expertise regarding isolated STIC and determine current diagnostic and treatment strategies in German-speaking gynecological departments, highlighting its significance in improving patient outcomes.

Key Findings:
  • Differences in clinical management of isolated STIC were observed across German-speaking countries, indicating a need for improved communication and training.
  • Discrepancies exist between guideline recommendations and real-world practices regarding surgery and follow-up care, which may affect patient outcomes.
  • The prevalence of isolated STIC is significantly higher in BRCA mutation carriers compared to non-carriers, underscoring the importance of genetic testing.
Interpretation:

The findings highlight the urgent need for standardized clinical algorithms and consensus-based guidelines to ensure consistent care for patients with isolated STIC, ultimately improving patient outcomes.

Limitations:
  • The survey was exploratory and did not perform statistical tests, which may limit the generalizability of the findings.
  • Participation was voluntary, which may introduce bias in responses and affect the reliability of the data.
Conclusion:

Standardized guidelines are essential for managing isolated STIC to align clinical practices with evidence-based recommendations, ensuring better patient care.

Original Source(s)

Related Content